ArticleAngewandte Chemie (International ed. in English)2026
Aggregation-State Dynamics Drive Double Cooperativity Between Antimicrobial Peptides LL-37 and HNP1.
Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
The double cooperative effect between two major antimicrobial peptides, LL-37 and HNP1, where their combination enhances antimicrobial efficiency while reducing cytotoxicity, offers a promising strategy for developing safer and more effective antibiotics against antimicrobial resistance. However, the molecular mechanism driving this effect has remained unclear. In this study, a combination of total internal reflection fluorescence (TIRF) microscopy, Förster resonance energy transfer (FRET), nuclear magnetic resonance (NMR), and molecular dynamic simulation (MD) revealed that the double cooperative effect arises from the dynamic assembly and disassembly of LL-37/HNP1 aggregates, where the degree of aggregation governs membrane toxicity and therefore influences the cell fate. The aggregation is driven primarily through hydrophobic interactions between several amino acids within LL-37 and HNP1. Interestingly, in membranes, this aggregation state is regulated by the lipid composition, where only anionic lipids can break up the aggregates and disperse peptides in the membranes, leading to the gain of peptides' function. Taking the advantage of the lipid composition difference, this enables the aggregates to destroy bacterial membranes, whereas protect eukaryotic cell membranes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.